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Introduction 
A large number of oilseeds with genetically 
modified crop production traits have been developed 
in recent years. Examples include herbicide 
resistance, insect resistance, disease resistance and 
male sterility and restoration (Green and Salisbury 
1998). Gene technology also provides substantially 
increased opportunities to alter the composition of 
grains to better match current and emerging food 
and industrial uses. In particular, there is a major 
focus on the development of oilseed products as 
natural health products and functional foods. 
Natural health products 
Natural health products are used for treatment, 
mitigation or prevention of disease and/or 
maintaining or promoting health. These products 
include supplements like vitamins and essential fatty 
acids as well as nutraceuticals. Nutraceuticals are 
products isolated or purified from foods and 
generally sold in medicinal forms not associated with 
food. They are sold encapsulated or in bottles. 
Alpha-linolenic acid (omega-3) 
Alpha-linolenic acid is effective in lowering blood 
cholesterol levels, reducing clotting of blood platelets 
(reducing risk of stroke) and lowering blood 
pressure. There is the potential to increase levels of 
alpha-linolenic acid in linseed and other oilseeds, 
both through conventional breeding and 
biotechnology. 
Gamma-linolenic acid 
Gamma-linolenic acid is effective in reducing 
symptoms of rheumatoid arthritis, treating diabetic 
neuropathy and reducing symptoms of skin 
disorders, including atopic eczema and dermatitis. It 
is currently produced from evening primrose or 
borage. The ∆6-desaturase gene has been transferred 
into canola resulting in higher yields of gamma-
linolenic acid than in borage and evening primrose. 
Nutraceuticals 
Biotechnology is being used to develop a range of 
nutraceutical products in oilseeds. Examples include 
flu and rabies vaccines (addition of genes for viral 
proteins) and pharmaceutical peptides such as 
hirudin (a blood anti-coagulant protein produced by 
a gene from leeches) and thrombin. The oleosin 
proteins that encase the oil storage bodies in the seed 
have been successfully engineered to carry these high 
value pharmaceutical peptides (van Rooijen and 
Moloney 1995).  
Functional foods 
Functional foods are foods that demonstrate 
physiological benefits and/or reduce risk of chronic 
diseases beyond the basic nutritional function. 
High oleic, low linolenic acid 
One breeding objective has been to develop 
healthy, high-stability cooking oils that can be used 
directly in the food service sector without the need 
for hydrogenation. To ensure stability during long-
life cooking applications, oils must have relatively 
low levels of polyunsaturated fatty acids. In 
particular, linolenic acid must be very low as it is 
rapidly oxidised to give undesirable off-flavours. 
Currently, high-stability vegetable oils are obtained 
either by using imported palm oils that have naturally 
high stability, or by partially hydrogenating 
polyunsaturated oils (cottonseed, canola, soybean) to 
convert polyunsaturates back to monounsaturates 
and saturates. Both approaches are nutritionally 
undesirable, palm oils because they contain high 
levels of cholesterol-raising saturates, and 
hydrogenation because it results in production of 
cholesterol-raising trans fatty acids. It would be 
preferable to modify the fatty acid composition of 
locally-grown oilseeds to have the required 
nutritional and functional properties. This has now 
been achieved by the development of high-oleic 
forms of all the major oilseed crops, through either 
conventional breeding or through the inactivation of 
the ∆12-desaturase gene using gene silencing 
techniques. Silencing of ∆12-desaturase has been 
used to raise oleic acid levels to 89% and 75% in 
canola oil from Brassica napus and B. juncea 
respectively (Stoutjesdijk et al. 2000), and to 77% in 
cottonseed oil (Liu et al. 2000). Similar approaches 
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have been used to develop soybean oils with 88% 
oleic acid.  
High stearic acid 
As well as being used in liquid cooking 
applications, vegetable oils are also hydrogenated to 
produce solid fats for use in margarines and 
shortenings. In this case, hydrogenation is used to 
increase the level of high melting-point saturates and 
trans fatty acids. Stearic acid (C18:0) is a high melting 
point saturate that is known to be neutral with 
respect to blood cholesterol levels, however it is only 
a very minor component in the main seed oils. The 
development of oilseeds with naturally high levels of 
stearic acid should provide oils having melting points 
high enough for their direct use in solid fat 
applications without the need for hydrogenation. 
Oils with up to 40% stearic acid have now been 
developed in canola (Knutzon et al. 1992) and in 
cottonseed (Liu et al. 2000) by using gene technology 
to silence the ∆9-desaturase gene in the seed. The 
use of such high-stearic oils instead of hydrogenated 
oils as the hardstock in margarines could have 
positive nutritional effects through replacement of 
cholesterol-raising trans fatty acids with neutral 
stearic acid. 
Alpha-tocopherols (vitamin E) 
Tocopherols are essential nutrients and natural 
anti-oxidants. They are beneficial in the treatment of 
atherosclerotic disease. Increases in the levels of 
highly effective antioxidants in food oils would be a 
valuable addition to the human diet as well as 
providing enhanced stability to the oils during 
processing. Biotechnology has been used to increase 
levels of alpha-tocopherols in Arabidopsis. 
Phytosterols 
Dietary cholesterol is readily absorbed into the 
bloodstream. Phytosterols (for example, 
brassicasterol, stigmasterol) are not absorbed and 
they reduce the absorption of dietary cholesterol. In 
clinical trials, margarines with 8% phytosterols were 
able to significantly reduce blood cholesterol levels. 
These phytosterol-containing margarines have 
recently been introduced onto the Australian market 
under the Logicol® and ProActiv® brands. 
Phytosterols are currently obtained as by-products of 
pine wood pulping or sunflower oil distillates. The 
possibility exists to use gene technology to greatly 
increase the naturally low levels of phytosterols in 
oils up to levels that have a nutritional benefit. 
Canola and soybean oils with 25% phytosterols 
have recently been produced by over-expressing the 
rate limiting enzyme in sterol synthesis. 
Beta-carotene (Golden mustard) 
Approximately 250 million people worldwide 
suffer from vitamin A deficiency. Vitamin A 
deficiency causes vision impairment, inability to 
absorb proteins and nutrients and reduced immune 
function. One of the highest profile applications of 
gene technology in human nutrition has been the 
recent development of rice containing β-carotene, 
the compound that the body converts into vitamin 
A. This product has the potential to alleviate vitamin 
A deficiency in many parts of the developing world. 
It was achieved by the introduction of genes for the 
three key enzymes in the β-carotene pathway, 
namely phytoene synthase, carotene desaturase and 
lycopene β-cyclase (Ye et al. 2000). 
Seed oils also contain low levels of β-carotene 
and research has shown that β-carotene levels in 
canola seed can be raised up to 50-fold by the 
introduction of the phytoene desaturase gene 
targeted to the plastid (Shewmaker et al. 1999). As β-
carotene is lipid-soluble, the majority of it will be 
extracted in the seed oil. Golden mustard (B. juncea) 
oil high in β-carotene is now being developed using 
biotechnology, especially focussed at India (James 
2001).  
Long chain polyunsaturated fatty acids (‘Fish oils’) 
Long-chain polyunsaturated fatty acids (LC-
PUFA) such as arachidonic acid (C20:4ω6, AA), 
eicosapentanoic acid (C20:5ω3, EPA) and 
docosahexanoic acid (C22:6ω3, DHA), have been 
demonstrated to have important roles in brain and 
retinal development, and as precursors for synthesis 
of various prostaglandins regulating important bodily 
functions, such as anti-inflammatory reactions and 
blood platelet aggregation. Although the human 
body can produce LC-PUFA by elongation and 
desaturation of dietary linoleic acid (C18:2) and α-
linolenic acid (C18:3), it does so inefficiently. It is 
therefore important to have an adequate dietary 
intake of these fatty acids, with marine oils a rich 
source of EPA and DHA. However, concerns about 
the ability of global fish stocks to meet this 
requirement in the long term have lead to interest in 
developing oilseeds that naturally contain moderate 
to high levels of LC-PUFA. 
The LC-PUFA fatty acids present in fish oils are 
the result of accumulation of ingested fatty acids 
originating from microalgae. A number of research 
groups have now cloned elongase and desaturase 
genes responsible for LC-PUFA synthesis from 
micro-organisms, and these genes are being 
introduced into oilseeds in order to assemble the 
pathway for synthesis of LC-PUFA from linoleic 
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acid and α-linolenic acid (Parker-Barnes et al. 2000). 
Recently, the accumulation of up to 17% stearidonic 
acid (C18:4ω3, SDA) has been achieved in rapeseed 
by the introduction of genes for ∆6-, ∆12- and ∆15-
desaturases (Ursin et al. 2000). Furthermore 
nutritional studies with SDA indicate that it is 
efficiently converted to EPA and DHA by the 
human body, suggesting that it may be valuable to 
produce seed oils rich in SDA, as well as assembling 
the full EPA/DHA pathway in oilseeds. Thus it is 
highly likely that genetically modified oilseeds having 
nutritionally effective levels of LC-PUFA will soon 
be a reality. 
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